---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-011838"
form_type: "8-K"
ticker: "ABEO"
cik: "0000318306"
company_name: "ABEONA THERAPEUTICS INC."
filed_at: "2023-04-11T23:59:59+00:00"
generated_at: "2026-06-17T03:53:26.442546+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Abeona Therapeutics reduces board size to seven; Chairman moves director class for compliance

## Summary
- Board size decreased from nine to seven directors, effective at 2023 Annual Shareholder Meeting.
- Chairman Michael Amoroso relinquished Class 2 seat and was appointed Class 1 director to maintain equal class sizes.
- Amoroso's service is deemed continuous; no new compensatory arrangements were entered into.

## SEC filing metadata
- accession: 0001493152-23-011838
- form_type: 8-K
- ticker: ABEO
- cik: 0000318306
- company_name: ABEONA THERAPEUTICS INC.
- filed_at: 2023-04-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/318306/000149315223011838/0001493152-23-011838-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/318306/000149315223011838/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-011838
- JSON: https://secwatch.observer/filing/0001493152-23-011838.json
- Plain text: https://secwatch.observer/filing/0001493152-23-011838.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.